2315 — Biocytogen Pharmaceuticals Beijing Co Balance Sheet
0.000.00%
Last trade - 00:00
- HK$2.96bn
- HK$3.11bn
- CNY716.91m
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Cash | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 897 | 566 | 611 | 408 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 81.9 | 118 | 112 | 148 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 1,148 | 874 | 919 | 723 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 1,136 | 1,391 | 1,599 | 1,451 |
Net Intangible Assets | ||||
Long Term Investments | ||||
Other Long Term Assets | ||||
Total Assets | 2,327 | 2,303 | 2,800 | 2,449 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 328 | 447 | 606 | 578 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Minority Interest | ||||
Total Other Liabilities | ||||
Total Liabilities | 873 | 1,056 | 1,654 | 1,664 |
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
ESOP Debt Guarantee | ||||
Other Equity | ||||
Total Equity | 1,453 | 1,247 | 1,146 | 786 |
Total Liabilities & Shareholders' Equity | 2,327 | 2,303 | 2,800 | 2,449 |
Total Common Shares Outstanding |